CABA - Company ID 0001759138
Cabaletta Bio, Inc. trades as CABA. This page tracks Cabaletta Bio, Inc. through 419 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| SCHEDULE 13G/A | - | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 |
| Major company event | 8-K | 2026-05-14 |
| Major company event | 8-K | 2026-05-14 |
| Major company event | 8-K | 2026-05-04 |
| Prospectus supplement | 424B5 | 2026-05-04 |
| Major company event | 8-K | 2026-05-04 |
| Annual report to shareholders | ARS | 2026-04-28 |
The largest companies sharing Cabaletta Bio, Inc.'s SEC industry classification (biological products, (no diagnostic substances)).
In its latest fiscal year Cabaletta Bio, Inc. reported a net loss of $167.86M.